Wayfinding Task on Smartphone Can Detect Subjective Cognitive Decline
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 15, 2024 -- Subtle cognitive changes in patients with subjective cognitive decline can be identified using smartphone data collected during a wayfinding task, according to a study published online Oct. 3 in PLOS Digital Health.
Jonas Marquardt, from the German Center for Neurodegenerative Diseases in Magdeburg, and colleagues examined the differences in smartphone-assisted wayfinding behavior in a sample of patients with subjective cognitive decline who scored normally on neuropsychological assessments and cognitively healthy older and younger adults. Participants had to find locations along a short route on the medical campus of Magdeburg University, guided by a mobile application ("Explore").
The researchers found that performance measures that were extracted from GPS and user input data could differentiate between the groups. In older participants, the number of orientation stops was predictive of subjective cognitive decline status.
"With the rising adoption of smartphones and wearables in older age groups, data from mobile applications like the 'Explore' app could ultimately be used as a screening tool to stratify subjects with regard to the need of extended cognitive and clinical diagnostics," the authors write.
One author disclosed financial ties to neotiv GmbH.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-16 12:00
Read more
- 2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
- Insurer Anthem Rescinds Anesthesia Policy Change After Backlash
- Trump Says He'll Try to Rid U.S. of Daylight Saving Time
- Supreme Court to Decide on South Carolina's Bid to Cut Funding for Planned Parenthood
- Team Sports Score Big Points for Your Child's Brain, Study Finds
- Scientists Develop Whole New Form of Effective Asthma Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions